119 related articles for article (PubMed ID: 29636220)
1. Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity.
May-Dracka TL; Arduini R; Bertolotti-Ciarlet A; Bhisetti G; Brickelmaier M; Cahir-McFarland E; Enyedy I; Fontenot JD; Hesson T; Little K; Lyssikatos J; Marcotte D; McKee T; Murugan P; Patterson T; Peng H; Rushe M; Silvian L; Spilker K; Wu P; Xin Z; Burkly LC
Bioorg Med Chem Lett; 2018 Jun; 28(10):1964-1971. PubMed ID: 29636220
[TBL] [Abstract][Full Text] [Related]
2. GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease.
Chuang HC; Tsai CY; Hsueh CH; Tan TH
Sci Adv; 2018 Sep; 4(9):eaat5401. PubMed ID: 30214937
[TBL] [Abstract][Full Text] [Related]
3. MAP4K3/GLK in autoimmune disease, cancer and aging.
Chuang HC; Tan TH
J Biomed Sci; 2019 Oct; 26(1):82. PubMed ID: 31640697
[TBL] [Abstract][Full Text] [Related]
4. The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells.
Chuang HC; Lan JL; Chen DY; Yang CY; Chen YM; Li JP; Huang CY; Liu PE; Wang X; Tan TH
Nat Immunol; 2011 Oct; 12(11):1113-8. PubMed ID: 21983831
[TBL] [Abstract][Full Text] [Related]
5. MAP4K3/GLK inhibits Treg differentiation by direct phosphorylating IKKβ and inducing IKKβ-mediated FoxO1 nuclear export and Foxp3 downregulation.
Chi JN; Yang JY; Hsueh CH; Tsai CY; Chuang HC; Tan TH
Theranostics; 2022; 12(13):5744-5760. PubMed ID: 35966593
[No Abstract] [Full Text] [Related]
6. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D
J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200
[TBL] [Abstract][Full Text] [Related]
7. Germinal-center kinase-like kinase co-crystal structure reveals a swapped activation loop and C-terminal extension.
Marcotte D; Rushe M; M Arduini R; Lukacs C; Atkins K; Sun X; Little K; Cullivan M; Paramasivam M; Patterson TA; Hesson T; D McKee T; May-Dracka TL; Xin Z; Bertolotti-Ciarlet A; Bhisetti GR; Lyssikatos JP; Silvian LF
Protein Sci; 2017 Feb; 26(2):152-162. PubMed ID: 27727493
[TBL] [Abstract][Full Text] [Related]
8. MAP4K Family Kinases in Immunity and Inflammation.
Chuang HC; Wang X; Tan TH
Adv Immunol; 2016; 129():277-314. PubMed ID: 26791862
[TBL] [Abstract][Full Text] [Related]
9. Germinal center kinase-like kinase overexpression in T cells as a novel biomarker in rheumatoid arthritis.
Chen YM; Chuang HC; Lin WC; Tsai CY; Wu CW; Gong NR; Hung WT; Lan TH; Lan JL; Tan TH; Chen DY
Arthritis Rheum; 2013 Oct; 65(10):2573-82. PubMed ID: 23817999
[TBL] [Abstract][Full Text] [Related]
10. How can the structure of germinal-center kinase-like kinase help us in drug discovery?
Silvian L
Future Med Chem; 2017 Sep; 9(14):1583-1585. PubMed ID: 28828898
[No Abstract] [Full Text] [Related]
11. Development of novel molecular probes of the Rio1 atypical protein kinase.
Mielecki M; Krawiec K; Kiburu I; Grzelak K; Zagórski W; Kierdaszuk B; Kowa K; Fokt I; Szymanski S; Swierk P; Szeja W; Priebe W; Lesyng B; LaRonde-LeBlanc N
Biochim Biophys Acta; 2013 Jul; 1834(7):1292-301. PubMed ID: 23523885
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases.
Jimenez JM; Boyall D; Brenchley G; Collier PN; Davis CJ; Fraysse D; Keily SB; Henderson J; Miller A; Pierard F; Settimo L; Twin HC; Bolton CM; Curnock AP; Chiu P; Tanner AJ; Young S
J Med Chem; 2013 Mar; 56(5):1799-810. PubMed ID: 23398373
[TBL] [Abstract][Full Text] [Related]
13. Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy.
Wang J; Jin W; Zhou X; Li J; Xu C; Ma Z; Wang J; Qin L; Zhou B; Ding W; Gao T; Yao H; Chen Z
J Med Chem; 2020 Nov; 63(21):12978-12991. PubMed ID: 33100009
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
[TBL] [Abstract][Full Text] [Related]
15. A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.
Kunikawa S; Tanaka A; Takasuna Y; Tasaki M; Chida N
Bioorg Med Chem; 2018 Nov; 26(20):5499-5509. PubMed ID: 30274941
[TBL] [Abstract][Full Text] [Related]
16. C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.
Subrath J; Wang D; Wu B; Niu C; Boschelli DH; Lee J; Yang X; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 Sep; 19(18):5423-5. PubMed ID: 19682896
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Docking Study and Kinase Inhibitory Activity of a Number of New Substituted Pyrazolo[3,4-c]pyridines.
Sklepari M; Lougiakis N; Papastathopoulos A; Pouli N; Marakos P; Myrianthopoulos V; Robert T; Bach S; Mikros E; Ruchaud S
Chem Pharm Bull (Tokyo); 2017; 65(1):66-81. PubMed ID: 28049917
[TBL] [Abstract][Full Text] [Related]
18. Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2).
Tan L; Nomanbhoy T; Gurbani D; Patricelli M; Hunter J; Geng J; Herhaus L; Zhang J; Pauls E; Ham Y; Choi HG; Xie T; Deng X; Buhrlage SJ; Sim T; Cohen P; Sapkota G; Westover KD; Gray NS
J Med Chem; 2015 Jan; 58(1):183-96. PubMed ID: 25075558
[TBL] [Abstract][Full Text] [Related]
19. Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).
Goldberg FW; Ward RA; Powell SJ; Debreczeni JE; Norman RA; Roberts NJ; Dishington AP; Gingell HJ; Wickson KF; Roberts AL
J Med Chem; 2009 Dec; 52(23):7901-5. PubMed ID: 19736928
[TBL] [Abstract][Full Text] [Related]
20. Effect of AS2521780, a novel PKCθ selective inhibitor, on T cell-mediated immunity.
Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Matsuoka H; Suzuki K; Ishikawa T; Tanaka A; Higashi Y
Eur J Pharmacol; 2014 Dec; 745():217-22. PubMed ID: 25445039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
